Dudediligence.

Pfizer Inc

PFENYSE · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$17.70BSep ’24$17.76BDec ’24$13.71BMar ’25$14.65BJun ’25$16.65BSep ’25$17.56BDec ’25$14.45BMar ’26$15.03BJun ’26
Net income, by quarter
$4.46BSep ’24$410.0MDec ’24$2.97BMar ’25$2.91BJun ’25$3.54BSep ’25−$1.65BDec ’25$2.69BMar ’26−$248.0MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$81.29B$101.2B$59.55B$63.63B$62.58B
Gross profit$50.47B$66.83B$34.60B$45.78B$46.51B
Net income$21.98B$31.37B$2.12B$8.03B$7.77B
Operating cash flow$32.58B$29.27B$8.70B$12.74B$11.70B
Free cash flow$29.87B$26.03B$4.79B$9.84B$9.07B
Cash$1.94B$416.0M$2.85B$1.04B$1.14B
Debt$38.44B$35.83B$71.89B$64.35B$64.80B
Shares outstanding9.47B9.52B9.56B9.59B9.62B